Phase I Study of Pazopanib in Combination With Weekly Paclitaxel and Carboplatin to Assess the Safety and Tolerability in Patients With Advanced Solid Tumors
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2018
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Pazopanib (Primary)
- Indications Breast cancer; Solid tumours
- Focus Adverse reactions
- 06 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 06 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 20 Jan 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.